Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer

被引:113
|
作者
Jilg, Cordula A. [1 ]
Drendel, Vanessa [2 ]
Rischke, H. Christian [3 ,4 ]
Beck, Teresa [4 ]
Vach, Werner [5 ,6 ]
Schaal, Kathrin [1 ]
Wetterauer, Ulrich [1 ]
Schultze-Seemann, Wolfgang [1 ]
Meyer, Philipp T. [4 ,7 ]
机构
[1] Univ Freiburg, Fac Med, Med Ctr, Dept Urol, Freiburg, Germany
[2] Univ Freiburg, Fac Med, Inst Pathol, Freiburg, Germany
[3] Univ Freiburg, Fac Med, Med Ctr, Dept Radiat Oncol, Freiburg, Germany
[4] Univ Freiburg, Fac Med, Med Ctr, Dept Nucl Med, Freiburg, Germany
[5] Univ Freiburg, Fac Med, Inst Med Biometry & Stat, Freiburg, Germany
[6] Univ Freiburg, Med Ctr, Freiburg, Germany
[7] DKTK, German Canc Consortium, Partner Site Freiburg, Freiburg, Germany
来源
THERANOSTICS | 2017年 / 7卷 / 06期
关键词
prostate cancer; lymph node metastases; PSMA-PET/CT; salvage lymph node dissection; salvage lymphadenectomy; EAU GUIDELINES; PET/CT; LIGAND;
D O I
10.7150/thno.18421
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: By targeting the prostate-specific membrane antigen (PSMA) on prostate cancer (PCa) cells PSMA-PET/CT shows great potential in locating the site of biochemical recurrence even at low PSA (Prostate-specific antigen)-levels. Accurate imaging of PCa recurrent lymph node metastases (LNM) is crucial for metastases directed therapies such as salvage-lymph node dissection (salvage-LND). Objective: To evaluate the diagnostic accuracy of PSMA-PET/CT for detection of affected lymph-node regions at salvage-LND for nodal recurrence of PCa. Design, setting and participants: 30 patients with the suspicion of exclusively nodal PCa-relapse after primary therapy underwent a template pelvic and/or retroperitoneal salvage-LND after whole body 68-Ga-PSMA-PET/CT. The diagnostic accuracy of PET/CT was evaluated in comparison to the histopathology of 965 resected lymph nodes (LN) dissected from 68 main regions (pelvic left/right, retroperitoneal) and 289 subregions (common iliac, external iliac, obturator, internal iliac, presacral, aortic-bifurcation, aortal, caval). LNM and tumor deposits in LNM were measured bidimensionally in the histopathology. PSMA-expression was analyzed by immunohistochemistry in LNM. Results: LNM were present in 11.4% of the resected LN (110/965) resulting in 45 positive main regions and 85 positive subregions. PET/CT was true positive in 41 main regions and 69 subregions. Three PET-negative main regions and 16 PET-negative subregions finally contained LNM, the majority of these false negative subregions (13/16) were in neighboring regions of true-positive subregions. Sensitivity, specificity, positive predictive value, negative predictive value and accuracy were: main region-based 93.2%, 100%, 100%, 88.9% and 95.6%, subregion-based 81.2%, 99.5%, 98.6%, 92.7 and 94.1%. Median short diameters of tumor deposits in LNM resected from false-negative subregions (1.3 mm) were significantly smaller than in LNM removed from true-positive subregions (5.5 mm, p<0.0001). Based on anatomical subregions containing just one LNM, the necessary short diameter of tumor deposits in LNM required to reach a detection rate of 50% and 90% was estimated to be >= 2.3 mm and >= 4.5 mm, respectively. Conclusion: In men with biochemical PCa-relapse and positive PSMA-PET/CT, PET/CT detects metastatic affected anatomical regions with high accuracy at a main region and at a subregion-level. If the decision for salvage-LND is prompted by a positive PSMA-PET/CT, the size of metastases is crucial for accurate detection of affected regions. All LNM showed a clear PSMA-expression in the immunohistochemistry. Further studies need to investigate how to translate the high anatomical correlation observed between PET/CT and surgical findings into optimal approaches for target salvage-LND.
引用
收藏
页码:1770 / 1780
页数:11
相关论文
共 50 条
  • [21] 68Ga-HBED PSMA PET/CT IN THE INITIAL STAGING OF PROSTATE CANCER
    Nadebaum, D.
    Grummet, J.
    Beech, P.
    Barber, T.
    Yap, K.
    Cherk, M.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 20 - 20
  • [22] Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma
    Carsten-Oliver Sahlmann
    Birgit Meller
    Caroline Bouter
    Christian Oliver Ritter
    Philipp Ströbel
    Joachim Lotz
    Lutz Trojan
    Johannes Meller
    Sameh Hijazi
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 898 - 905
  • [23] 68GA-PSMA PET/CT IMPROVES BIOCHEMICAL RESPONSE AFTER SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENCE IN PROSTATE CANCER PATIENTS
    Herlemann, Annika
    Kretschmer, Alexander
    Buchner, Alexander
    Karl, Alexander
    Tritschler, Stefan
    El-Malazi, Lina
    Wenter, Vera
    Ilhan, Harun
    Bartenstein, Peter
    Stief, Christian Georg
    Gratzke, Christian
    JOURNAL OF UROLOGY, 2017, 197 (04): : E452 - E452
  • [24] Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma
    Sahlmann, Carsten-Oliver
    Meller, Birgit
    Bouter, Caroline
    Ritter, Christian Oliver
    Stroebel, Philipp
    Lotz, Joachim
    Trojan, Lutz
    Meller, Johannes
    Hijazi, Sameh
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (05) : 898 - 905
  • [25] Impact of Ga-68 HBED-CC PSMA PET/CT on therapeutic management of patients with prostate cancer
    Schreiter, Vera
    Schreiter, Nils
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [26] PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer
    Giesel, Frederik L.
    Fiedler, H.
    Stefanova, M.
    Sterzing, F.
    Rius, M.
    Kopka, K.
    Moltz, J. H.
    Afshar-Oromieh, A.
    Choyke, P. L.
    Haberkorn, U.
    Kratochwil, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (12) : 1794 - 1800
  • [27] PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer
    Frederik L. Giesel
    H. Fiedler
    M. Stefanova
    F. Sterzing
    M. Rius
    K. Kopka
    J. H. Moltz
    A. Afshar-Oromieh
    P. L. Choyke
    U. Haberkorn
    C. Kratochwil
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1794 - 1800
  • [28] Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy
    Rauscher, Isabel
    Maurer, Tobias
    Beer, Ambros J.
    Graner, Frank-Philipp
    Haller, Bernhard
    Weirich, Gregor
    Doherty, Alan
    Gschwend, Juergen E.
    Schwaiger, Markus
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (11) : 1713 - 1719
  • [29] 68GA-PSMA PET/CT PROVIDES ACCURATE STAGING OF LYMPH NODE REGIONS PRIOR TO LYMPH NODE DISSECTION IN PATIENTS WITH PROSTATE CANCER
    Herlemann, Annika
    Wenter, Vera
    Kretschmer, Alexander
    Bartenstein, Peter
    Stief, Christian G.
    Gratzke, Christian
    Fendler, Wolfgang P.
    JOURNAL OF UROLOGY, 2016, 195 (04): : E992 - E992
  • [30] Accuracy of 68Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer
    Gomes Barbosa, Alan Roger
    Amaral, Breno Santos
    Lourenco, Danilo Budib
    Bianco, Bianca
    Gushiken, Felipe Arakaki
    Apezzato, Marcelo
    Silva, Julia Francisco
    da Cunha, Marcelo Livorsi
    Filippi, Renee Zon
    Baroni, Ronaldo Hueb
    Lemos, Gustavo Caserta
    Carneiro, Arie
    EINSTEIN-SAO PAULO, 2022, 20 : eAO6599